Mesa Laboratories Inc
NASDAQ:MLAB
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
84.55
140.86
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MLAB stock under the Base Case scenario is 117.73 USD. Compared to the current market price of 118.45 USD, Mesa Laboratories Inc is Overvalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Mesa Laboratories Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MLAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Mesa Laboratories Inc
Balance Sheet Decomposition
Mesa Laboratories Inc
Current Assets | 106.7m |
Cash & Short-Term Investments | 28.5m |
Receivables | 35.6m |
Other Current Assets | 42.7m |
Non-Current Assets | 333.7m |
PP&E | 31.4m |
Intangibles | 289.2m |
Other Non-Current Assets | 13.1m |
Current Liabilities | 54.9m |
Accounts Payable | 5.7m |
Accrued Liabilities | 29.3m |
Other Current Liabilities | 20m |
Non-Current Liabilities | 234.8m |
Long-Term Debt | 208.5m |
Other Non-Current Liabilities | 26.3m |
Earnings Waterfall
Mesa Laboratories Inc
Revenue
|
223.7m
USD
|
Cost of Revenue
|
-84.4m
USD
|
Gross Profit
|
139.3m
USD
|
Operating Expenses
|
-130.6m
USD
|
Operating Income
|
8.7m
USD
|
Other Expenses
|
-259m
USD
|
Net Income
|
-250.3m
USD
|
Free Cash Flow Analysis
Mesa Laboratories Inc
USD | |
Free Cash Flow | USD |
MLAB Profitability Score
Profitability Due Diligence
Mesa Laboratories Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Mesa Laboratories Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
MLAB Solvency Score
Solvency Due Diligence
Mesa Laboratories Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Mesa Laboratories Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MLAB Price Targets Summary
Mesa Laboratories Inc
According to Wall Street analysts, the average 1-year price target for MLAB is 146.2 USD with a low forecast of 121.2 USD and a high forecast of 168 USD.
Dividends
Current shareholder yield for MLAB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MLAB Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.
Officers
The intrinsic value of one MLAB stock under the Base Case scenario is 117.73 USD.
Compared to the current market price of 118.45 USD, Mesa Laboratories Inc is Overvalued by 1%.